AstraZeneca's long-acting antibody combination is both able to prevent and treat Covid-19, according to the phase three results released on Monday.
The drug, AZD7442, is...
Covid-19 disease severity seems to be affected by the characteristics of white blood cells called granulocytes, which are part of the innate immune system.
Combined...